1242 related articles for article (PubMed ID: 30608666)
1. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.
Marinko JT; Huang H; Penn WD; Capra JA; Schlebach JP; Sanders CR
Chem Rev; 2019 May; 119(9):5537-5606. PubMed ID: 30608666
[TBL] [Abstract][Full Text] [Related]
2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
Tao YX; Conn PM
Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
[TBL] [Abstract][Full Text] [Related]
4. Chaperoning osteogenesis: new protein-folding disease paradigms.
Makareeva E; Aviles NA; Leikin S
Trends Cell Biol; 2011 Mar; 21(3):168-76. PubMed ID: 21183349
[TBL] [Abstract][Full Text] [Related]
5. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
[TBL] [Abstract][Full Text] [Related]
6. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
Lindquist SL; Kelly JW
Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
[TBL] [Abstract][Full Text] [Related]
7. Using pharmacological chaperones to restore proteostasis.
Wang YJ; Di XJ; Mu TW
Pharmacol Res; 2014 May; 83():3-9. PubMed ID: 24747662
[TBL] [Abstract][Full Text] [Related]
8. The Misfolding of Proteins.
Argyrou A
Adv Exp Med Biol; 2020; 1195():249-254. PubMed ID: 32468483
[TBL] [Abstract][Full Text] [Related]
9. Chemical Biology Framework to Illuminate Proteostasis.
Sebastian RM; Shoulders MD
Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
[TBL] [Abstract][Full Text] [Related]
10. Extracellular protein homeostasis in neurodegenerative diseases.
Wilson MR; Satapathy S; Vendruscolo M
Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
[TBL] [Abstract][Full Text] [Related]
11. Protein misfolding in disease and small molecule therapies.
Gomes CM
Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
Sloan LA; Fillmore MC; Churcher I
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in targeting protein misfolding diseases.
Denny RA; Gavrin LK; Saiah E
Bioorg Med Chem Lett; 2013 Apr; 23(7):1935-44. PubMed ID: 23454013
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
15. Protein solubility and protein homeostasis: a generic view of protein misfolding disorders.
Vendruscolo M; Knowles TP; Dobson CM
Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21825020
[TBL] [Abstract][Full Text] [Related]
16. Roles of the nucleotide exchange factor and chaperone Hsp110 in cellular proteostasis and diseases of protein misfolding.
Yakubu UM; Morano KA
Biol Chem; 2018 Sep; 399(10):1215-1221. PubMed ID: 29908125
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
18. Assistance for Folding of Disease-Causing Plasma Membrane Proteins.
Biomolecules; ; . PubMed ID: 32392767
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]